Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
Zhengwei ChenGuoxiong ChengPublished in: Recent patents on anti-cancer drug discovery (2023)
Fatty acid metabolism genes affect the development of gastric adenocarcinoma and can predict the survival prognosis, tumor mutational load characteristics, and drug therapy sensitivity of STAD patients, which can help explore more effective immunotherapy targets for GC.
Keyphrases
- poor prognosis
- fatty acid
- end stage renal disease
- long non coding rna
- newly diagnosed
- ejection fraction
- chronic kidney disease
- squamous cell carcinoma
- prognostic factors
- genome wide
- emergency department
- peritoneal dialysis
- stem cells
- gene expression
- mesenchymal stem cells
- patient reported outcomes
- bone marrow
- cell therapy
- locally advanced
- adverse drug